These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1065 related articles for article (PubMed ID: 17683854)
41. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up. Chaplin BJ; Wildhagen MF; Schroder FH; Kirkels WJ; Bangma CH Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322 [TBL] [Abstract][Full Text] [Related]
42. Current results and patient selection for nerve-sparing radical retropubic prostatectomy. Steiner MS Semin Urol Oncol; 1995 Aug; 13(3):204-14. PubMed ID: 8521134 [TBL] [Abstract][Full Text] [Related]
43. Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Gupta A; Lotan Y; Ashfaq R; Roehrborn CG; Raj GV; Aragaki CC; Montorsi F; Shariat SF Eur Urol; 2009 May; 55(5):1124-33. PubMed ID: 18585843 [TBL] [Abstract][Full Text] [Related]
44. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. Carver BS; Bianco FJ; Scardino PT; Eastham JA J Urol; 2006 Aug; 176(2):564-8. PubMed ID: 16813890 [TBL] [Abstract][Full Text] [Related]
45. Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Yamamoto S; Yonese J; Kawakami S; Ohkubo Y; Tatokoro M; Komai Y; Takeshita H; Ishikawa Y; Fukui I Eur Urol; 2007 Sep; 52(3):696-701. PubMed ID: 17412490 [TBL] [Abstract][Full Text] [Related]
46. Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery. Suardi N; Moschini M; Gallina A; Gandaglia G; Abdollah F; Capitanio U; Bianchi M; Tutolo M; Passoni N; Salonia A; Hedlund P; Rigatti P; Montorsi F; Briganti A BJU Int; 2013 May; 111(5):717-22. PubMed ID: 22726993 [TBL] [Abstract][Full Text] [Related]
47. The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy. Rodriguez-Covarrubias F; Larre S; De La Taille A; Abbou CC; Salomon L BJU Int; 2008 Feb; 101(3):305-7. PubMed ID: 17941921 [TBL] [Abstract][Full Text] [Related]
48. Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins. Simon MA; Kim S; Soloway MS J Urol; 2006 Jan; 175(1):140-4; discussion 144-5. PubMed ID: 16406892 [TBL] [Abstract][Full Text] [Related]
49. Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancer. Macdonald OK; Lee RJ; Snow G; Lee CM; Tward JD; Middleton AW; Middleton GW; Sause WT Urology; 2007 Feb; 69(2):295-9. PubMed ID: 17320667 [TBL] [Abstract][Full Text] [Related]
50. Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy. Kübler HR; Tseng TY; Sun L; Vieweg J; Harris MJ; Dahm P J Urol; 2007 Aug; 178(2):488-92; discussion 492. PubMed ID: 17561133 [TBL] [Abstract][Full Text] [Related]
51. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml. Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384 [TBL] [Abstract][Full Text] [Related]
52. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer. Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811 [TBL] [Abstract][Full Text] [Related]
53. The effect of prostate weight on the outcomes of laparoscopic radical prostatectomy. Frota R; Turna B; Santos BM; Lin YC; Gill IS; Aron M BJU Int; 2008 Mar; 101(5):589-93. PubMed ID: 17922860 [TBL] [Abstract][Full Text] [Related]